<html>
<cdb>broida flra</cdb>
<doctype>Chapter 06: Subjects of Bargaining: Specific Applications of Negotiability Determinations</doctype>
<doctitle>Chapter 06: Subjects of Bargaining: Specific Applications of Negotiability Determinations, Subchapter 09: Drug Use and Drug Detection, Section B: Negotiability Framework, Subsection 09: Secondary Testing</doctitle>
<htmltext><head>
<style>
body {
-epub-hyphens:auto;
-webkit-hyphens:auto;
margin:1em;
}
a{
text-decoration:none;
}
img{
max-width:100%;
vertical-align:middle;
}
h1.Ch-Head {
font-family:"Arial", sans-serif;
font-size:2.34em;
font-weight:bold;
margin-bottom:0em;
margin-top:1em;
text-align:right;
text-indent:0em;
}
h1.Ch-Subhead {
font-family:"Arial", sans-serif;
font-size:2.17em;
font-weight:bold;
margin-bottom:1.5em;
margin-top:0.5em;
text-align:right;
text-indent:0em;
border-bottom-style:double;
padding-bottom:.2em;
}
p.noindent {
font-family:"Arial", sans-serif;
font-size:0.83em;
line-height:1.225;
margin-bottom:0.3em;
margin-top:0.5em;
text-align:justify;
text-indent:0em;
}
p.Body-Text-R {
font-family:"Arial", sans-serif;
font-size:0.83em;
line-height:1.225;
margin-bottom:0.3em;
margin-top:0.5em;
text-align:right;
text-indent:0em;
}
p.Body-Text-Rh {
font-family:"Arial", sans-serif;
font-size:0.83em;
line-height:1.225;
margin-bottom:0.3em;
margin-top:1em;
text-align:right;
text-indent:0em;
}
p.Body-Text-R2 {
font-family:"Arial", sans-serif;
font-size:0.83em;
line-height:1.225;
margin-bottom:0.3em;
margin-top:0.1em;
text-align:right;
text-indent:0em;
}
p.noindent-c {
font-family:"Arial", sans-serif;
font-size:0.83em;
line-height:1.225;
margin-bottom:0.3em;
margin-top:0.5em;
text-align:center;
text-indent:0em;
}
p.Body-Textl {
font-family:"Arial", sans-serif;
font-size:0.83em;
line-height:1.225;
margin-bottom:-0.3em;
margin-top:0.5em;
text-align:left;
text-indent:0em;
}
p.Body-Textc {
font-family:"Arial", sans-serif;
font-size:0.83em;
line-height:1.225;
margin-bottom:0.3em;
margin-top:0.5em;
text-align:center;
text-indent:0em;
}
h2.h2 {
font-family:"Arial", sans-serif;
font-size:1em;
font-weight:bold;
margin-bottom:0em;
margin-top:1em;
margin-left:3em;
text-align:left;
text-indent:0em;
}
span.space{
font-family:"Arial", sans-serif;
float:left;
margin-left:-3em;
}
span.spacet{
font-family:"Arial", sans-serif;
float:left;
margin-left:-2em;
}
h3.h3 {
font-family:"Arial", sans-serif;
font-size:1em;
font-weight:bold;
margin-left:6.5em;
margin-bottom:.5em;
margin-top:0.8em;
text-align:left;
text-indent:0em;
}
h4.h4 {
font-family:"Arial", sans-serif;
font-size:1em;
font-weight:bold;
margin-left:9.6em;
margin-bottom:.5em;
margin-top:0.8em;
text-align:left;
text-indent:0em;
}
h5.h5 {
font-family:"Arial", sans-serif;
font-size:1em;
font-weight:bold;
margin-left:12.5em;
margin-bottom:.5em;
margin-top:0.8em;
text-align:left;
text-indent:0em;
}
h6.h6 {
font-family:"Arial", sans-serif;
font-size:1em;
font-weight:bold;
margin-left:14.5em;
margin-bottom:.5em;
margin-top:0.8em;
text-align:left;
text-indent:0em;
}
div.box1{
font-family:"Arial", sans-serif;
margin:1em 2.5em 1em 2.5em;
border-style:double;
padding:0em;
}
div.box1a{
font-family:"Arial", sans-serif;
margin:1em 2.5em 1em 2em;
border-style:double;
padding:0em;
}
div.box1b{
font-family:"Arial", sans-serif;
margin:1em 2.5em 1em 1.8em;
border-style:double;
padding:0em;
}
h1.csh {
font-family:"Arial", sans-serif;
font-size:1em;
font-weight:normal;
margin:0em 0em .5em 0em;
padding:0.2em 0em 0.2em 0em;
font-weight:bold;
background-color:#E7E7E8;
text-align:center;
}
div.box2{
font-family:"Arial", sans-serif;
margin:0.6em 1.5em 0em 1.5em;
border:3px solid;
padding:0em 0.3em 0em 0.3em;
}
h1.csh1 {
font-family:"Arial", sans-serif;
font-size:0.87em;
font-weight:normal;
margin:0em 0em .5em 0em;
padding:0.2em 0em 0.2em 0em;
font-weight:bold;
text-align:center;
}
ul.bull1{
font-family:"Arial", sans-serif;
list-style-type:none;
margin:0.8em 0.3em 0.8em 0.1em;
padding:0em;
text-align:left;
}
ul.bull1p{
font-family:"Arial", sans-serif;
list-style-type:none;
margin:0.5em 0.3em 0em 0.1em;
padding:0em;
text-align:left;
}
ul.bull12{
font-family:"Arial", sans-serif;
list-style-type:none;
margin:0.5em 0.3em 0.2em 0.1em;
padding:0em;
text-align:left;
}
ul.list{
font-family:"Arial", sans-serif;
list-style-type:none;
margin:0em 0em 0.1em 1.8em;
padding:0em;
text-align:left;
}
ul.listl{
font-family:"Arial", sans-serif;
list-style-type:none;
margin:0em 0em 0.1em 0.5em;
padding:0em;
text-align:left;
}
ul.listn{
font-family:"Arial", sans-serif;
list-style-type:none;
font-size:0.83em;
margin:0em 0em 0.8em 0.5em;
text-align:left;
}
li.listr2{
font-family:"Arial", sans-serif;
font-size:0.83em;
margin:.5em 0em .7em 0em;
text-align:left;
padding:0em 0em 0em 0em;
}
li.listr2h{
font-family:"Arial", sans-serif;
font-size:0.83em;
margin:0.1em 0em 0em 2em;
text-align:left;
padding:0em 0em 0em 0em;
}
li.listr2h1{
font-family:"Arial", sans-serif;
font-size:0.83em;
margin:0.1em 0em 0em 4em;
text-align:left;
text-indent:-2.2em;
padding:0.2em 0em 0em 0em;
}
li.listr2n{
font-family:"Arial", sans-serif;
font-size:0.83em;
margin:0.8em 0.1em .0em 0.2em;
text-indent:-2.1em;
text-align:left;
padding:0em 0em 0em 0em;
}
span.nl2cn{
padding-right:1em;
}
span.nl2cnb{
padding-right:1.5em;
}
li.listr2b{
font-family:"Arial", sans-serif;
font-size:0.83em;
margin:0em 0em -0.8em 0em;
text-align:left;
padding:0em 0em 0em 0em;
}
span.nl2c{
padding-right:2em;
}
p.listr3{
font-family:"Arial", sans-serif;
font-size:inherit;
margin:.5em 0em .5em 0em;
text-align:left;
}
li.nl2ca {
font-family:"Arial", sans-serif;
font-size:0.83em;
margin:0.2em 0em 0em 0em;
padding:0em 0em 0em 0.2em;
text-align:left;
text-indent:0em;
}
li.nl2c {
font-family:"Arial", sans-serif;
font-size:0.83em;
margin:0.2em 0em 0em 0em;
padding:0em 0em 0em 2em;
text-align:left;
text-indent:0em;
}
span.nl2ca {
font-family:"Arial", sans-serif;
float:left;
margin:0em 0em 0em -2em;
}
blockquote{
font-family:"Arial", sans-serif;
margin:0.5em 0em 0.5em 1.8em;
}
p.noindent-1{
font-family:"Arial", sans-serif;
font-size:0.83em;
text-indent:0em;
margin:0.5em 0em 0em 3em;
text-align:justify;
}
p.Block-Quote1s{
font-family:"Arial", sans-serif;
font-size:0.83em;
text-indent:0em;
margin:0.5em 0em 1em 1.3em;
text-align:justify;
}
p.noindent-2{
font-family:"Arial", sans-serif;
font-size:0.83em;
text-indent:0em;
margin:0.5em 0em 0em 5em;
text-align:justify;
}
p.noindent-3{
font-family:"Arial", sans-serif;
font-size:0.83em;
text-indent:0em;
margin:0.5em 0em 0em 7em;
text-align:justify;
}
p.noindent-4{
font-family:"Arial", sans-serif;
font-size:0.83em;
text-indent:0em;
margin:0.5em 0em 0em 9em;
text-align:justify;
}
p.noindent-5{
font-family:"Arial", sans-serif;
font-size:0.83em;
text-indent:0em;
margin:0.5em 0em 0em 11em;
text-align:justify;
}
p.noindent-6{
font-family:"Arial", sans-serif;
font-size:0.83em;
text-indent:0em;
margin:0.5em 0em 0em 13em;
text-align:justify;
}
p.b2{
font-family:"Arial", sans-serif;
font-size:0.83em;
text-indent:0em;
margin:0.5em 0em 0em 4.5em;
text-align:left;
}
p.Body-Text-1 {
font-family:"Arial", sans-serif;
font-size:0.83em;
margin-bottom:.5em;
margin-top:.5em;
text-align:left;
text-indent:0em;
}
p.box-Body-Text {
font-family:"Arial", sans-serif;
font-size:0.83em;
margin-bottom:0em;
margin:0.5em 0 0.5em 0;
text-align:left;
text-indent:0em;
}
.Italic{
font-family:"Arial", sans-serif;
font-style:italic;
}
p.C-P-box-body-text {
font-family:"Arial", sans-serif;
font-size:0.83em;
margin-bottom:0em;
margin-top:0.5em;
margin-left:0em;
margin-right:0.2em;
text-align:left;
text-indent:0em;
}
p.C-P-box-body-text2 {
font-family:"Arial", sans-serif;
font-size:0.83em;
margin-bottom:0em;
margin-top:0.2em;
margin-left:0em;
margin-right:0.2em;
text-align:left;
padding:0.3em;
text-indent:0em;
}
p.C-P-box-body-text1 {
font-family:"Arial", sans-serif;
font-size:0.83em;
margin-bottom:0em;
margin-top:0.5em;
margin-left:0em;
margin-right:0.2em;
padding:0.2em;
text-align:left;
text-indent:0em;
}
p.C1-P-box-Body-Text1 {
font-family:"Arial", sans-serif;
font-size:0.83em;
margin-bottom:0em;
margin-top:0.5em;
margin-left:0em;
margin-right:0.2em;
padding:0.2em 0.2em 0.2em 0.7em;
text-align:left;
text-indent:0em;
}
p.td2b{
font-family:"Arial", sans-serif;
font-size:0.92em;
margin:0em 1em 0em 1em;
padding:0.3em 0em 0.3em 0em;
text-align:center;
text-indent:0em;
vertical-align:top;
background-color:#000000;
 color:#FFFFFF;
 white-space:nowrap;
 border-radius:20px;
}
p.td2b1{
font-family:"Arial", sans-serif;
font-size:1.2em !important;
margin:0em 1em 0em 1em;
padding:0.3em 0em 0.3em 0em;
text-align:center;
text-indent:0em;
vertical-align:top;
background-color:#000000;
 color:#FFFFFF;
 white-space:nowrap;
 border-radius:20px;
}
span.white{
font-family:"Arial", sans-serif;
color:white;
}
.img{
font-family:"Arial", sans-serif;
margin:0em 0.4em 0em 1em;
text-indent:0em;
}
td.practice-para, p.practice-para{
font-family:"Arial", sans-serif;
font-size:0.83em;
margin:.2em 1em 1em 1em;
text-align:left;
text-indent:0em;
}
td.practice-parats{
font-family:"Arial", sans-serif;
font-size:0.83em;
margin:.2em 1em 1em 1em;
text-align:left;
padding:0.5em 0em 0em 1.5em;
text-indent:0em;
}
td.practice-paratd{
font-family:"Arial", sans-serif;
font-size:0.83em;
margin:0em 1em 1em 0em;
padding:1.5em 2em 0em 2em;
text-align:center;
text-indent:0em;
}
td.practice-paratd1{
font-family:"Arial", sans-serif;
font-size:0.83em;
margin:0em 1em 1em 0em;
padding:1.5em 2em 0em 2em;
text-align:center;
border-right:2px solid;
text-indent:0em;
}
 p.practice-para1{
font-family:"Arial", sans-serif;
font-size:inherit;
margin:.5em 1em 0em 1em;
text-align:left;
text-indent:0em;
}
 p.practice-para2{
font-family:"Arial", sans-serif;
font-size:0.83em;
margin:.5em 1em 0em 1em;
text-align:left;
text-indent:0em;
}
div.black{
font-family:"Arial", sans-serif;
background-color:#000000;
color:#FFFFFF;
padding:.2em 1em .2em 1em;
}
.practice-para-h{
font-family:"Arial", sans-serif;
font-size:0.83em;
margin:.2em 0em 0em 0.8em;
text-align:center;
text-indent:0em;
}
.hang{
font-family:"Arial", sans-serif;
font-size:0.83em;
text-indent:0em;
margin:0.5em 0em 0em 6em;
text-align:left;
}
.list-para1{
font-family:"Arial", sans-serif;
font-size:inherit;
text-indent:0em;
margin:0.5em 0em 0em 2.7em;
text-align:left;
}
.list-para2{
font-family:"Arial", sans-serif;
font-size:inherit;
text-indent:0em;
margin:0.5em 0em 0em 3.7em;
text-align:left;
}
small.ch{
font-family:"Arial", sans-serif;
font-size:0.75em;
}
small.cs{
font-family:"Arial", sans-serif;
font-size:0.65em;
}
span.pad{
padding-right:2em;
}
table.table{
border-collapse:collapse;
max-width:100%;
margin:0em 1.5em 0em 1.5em;
}
table.table1{
border-collapse:collapse;
max-width:100%;
margin:-1em 1em 0em 1em;
margin-left:auto;
margin-right:auto;
}
div.practice{
font-family:"Arial", sans-serif;
font-size:1.25em;
margin:0em .5em 0 0;
text-align:center;
padding:.5em;
text-indent:0em;
background-color:#E7E7E8;
}
p.list {
font-family:"Arial", sans-serif;
font-size:0.83em;
line-height:1.225;
margin-bottom:0.3em;
margin-left:4.5em;
margin-top:0.5em;
text-align:justify;
text-indent:0em;
}
span.list{
font-family:"Arial", sans-serif;
float:left;
margin-left:-2em;
}
p.list2 {
font-family:"Arial", sans-serif;
font-size:0.83em;
line-height:1.225;
margin-bottom:0.3em;
margin-left:6.5em;
margin-top:0.5em;
text-align:justify;
text-indent:0em;
}
span.list2{
font-family:"Arial", sans-serif;
float:left;
margin-left:-2em;
}
p.noindent-Address {
font-family:"Arial", sans-serif;
font-size:0.83em;
line-height:1.225;
margin-bottom:0.25em;
margin-left:4.3em;
margin-top:0.25em;
text-align:justify;
text-indent:0em;
}
p.Body-Address-h {
font-family:"Arial", sans-serif;
font-size:0.83em;
line-height:1.225;
margin-bottom:0.25em;
margin-left:4.3em;
margin-top:1em;
text-align:justify;
text-indent:0em;
}
table.table
{
font-family:"Arial", sans-serif;
line-height:1.5;
margin-bottom: 1.5em;
margin-top:1.5em;
text-align:left;
text-indent:0em;
font-size:0.95em;
border-collapse:collapse;
width:100%;
}
table.table tbody td.td{
font-family:"Arial", sans-serif;
line-height:1.5;
font-size:1em;
font-weight:normal;
margin-bottom:0em;
margin-top:0em;
padding:0.5em;
text-indent:0em;
vertical-align:top;
color:#000;
text-align:left;
font-weight:normal;
}
table.table tbody td.td-c{
font-family:"Arial", sans-serif;
line-height:1.5;
font-size:1em;
font-weight:normal;
margin-bottom:0em;
margin-top:0em;
padding:0.5em;
text-indent:0em;
vertical-align:top;
color:#000;
text-align:center;
font-weight:normal;
}
table.table tbody td.td p.list {
font-family:"Arial", sans-serif;
font-size:1em;
line-height:1.225;
margin-bottom:0.3em;
margin-left:4.5em;
margin-top:0.5em;
text-align:justify;
text-indent:0em;
}
table.table tbody td.td span.list{
font-family:"Arial", sans-serif;
float:left;
margin-left:-2em;
}
span.small-d
{
font-size:0.75em;
}
span.Italic
{
font-family:"Arial", sans-serif;font-style:italic;}
span.BoldItalic
{
font-family:"Arial", sans-serif;font-style:italic;font-weight:bold;}
span.Bold
{font-family:"Arial", sans-serif;font-weight:bold;}
</style>
</head>
<body>
<section>
<h4 class="h4" id="sec6-260"><span class="space">9.</span> Secondary Testing</h4>
<p class="noindent">Proposals nonnegotiable as contrary to law in <span class="Italic">NFFE Local 15 and Dept. of Army, Army Armament, Munitions and Chem. Command, Rock Island</span>, 30 FLRA 1046, 1066, 1069-71 (1988), compelled secondary testing of employees if initial testing was positive. The proposal conflicted with provisions of the Executive Order that required the finding of illegal drug use to be confirmed on the basis of the same sample that tested positive on the initial test. <span class="Italic">See</span> <span class="Italic">AFGE, Dept. of Educ. Council of AFGE Locals and Dept. of Educ.</span>, 38 FLRA 1068, 1084-91 (1990) (Proposal 4), <span class="Italic">enforcement denied as to other proposals</span>, <span class="Italic">Dept. of Interior, Minerals Mgmt. Serv. v. FLRA</span>, 969 F.2d 1158, 1161-63 (D.C. Cir. 1992); <span class="Italic">Int'l Org. of Masters, Mates and Pilots and Panama Canal Comm'n</span>, 32 FLRA 269, 270-71 (1988) ("The second sentence of Proposal 1 provides employees who test positive on the first sample with the option not to test the second sample. Executive Order 12564 requires that employees who test positive for drug use must be disciplined. It also requires that prior to imposing discipline for drug use, initial positive drug tests must be confirmed by a further test of the initial sample. Because the second sentence makes the confirmative test voluntary, it is inconsistent with the requirement of the Executive Order for mandatory confirmation of an initial positive test."). For the same reason, a proposal was nonnegotiable that precluded management from acting on a single confirmed positive test and instead sought to withhold test results from management until there had been three positive confirmatory tests. <span class="Italic">See</span> <span class="Italic">NFFE Local 2058 and Army Aberdeen Proving Ground</span>, 31 FLRA 241, 249, 251 (1988); <span class="Italic">NFFE Local 1437 and Army Armament Research, Dev. and Eng'r Ctr., Dover</span>, 31 FLRA 101, 109, 111-12 (1988) (proposal requiring additional field tests before any confirmatory test was inconsistent with requirement of Executive Order 12564 that finding of illegal drug use must be based on confirmatory test of same initial sample).</p>
<p class="noindent"><span class="Italic">AFGE Local 3457 and Dept. of Interior, Minerals Mgmt. Serv.</span>, 42 FLRA 567, 580-81 (1991), ruled negotiable Proposal 4, obligating management to agree that any positive test results again be verified by a second gas chromatography/mass spectrometry test:</p>
<p class="noindent-1">We find that the proposal directly interferes with the Agency's right to determine its internal security practices under section 7106(a)(1) of the Statute. However, we also find that the proposal constitutes a negotiable appropriate arrangement under section 7106(b)(3) of the Statute.</p>
<p class="noindent-1">Proposal 4 requires that any positive test result will be verified by a second gas chromatography/mass spectrometry (GC/MS) test. Initially, we note that the proposal references a "2nd" GC/MS test. However, as both parties argue the applicability of the Guidelines, we assume for purposes of this decision that the GC/MS test referenced in the proposal is the technique used to test an initial positive result, and that the proposal is not intended to require that there be two GC/MS tests.</p>
<p class="noindent-1">Section 2.4(f)(1) of the Guidelines requires that "[a]ll specimens identified as positive on the initial test shall be confirmed using gas chromatography/mass spectrometry (GC/MS) techniques...." 53 Fed. Reg. 11983. The Agency argues that by incorporating a specific technique into the parties' agreement, with which the Agency would have to comply, the proposal impermissibly imposes a substantive limitation on the exercise of the Agency's right to determine its internal security practices. We agree.</p>
<p class="noindent-1">As we found in connection with Proposal 1, proposals that limit the range of management's determination as to the methods and equipment that are used to conduct drug tests directly interfere with management's right to determine its internal security practices by establishing substantive criteria governing the exercise of that right. Proposal 4 specifies the particular technique that the Agency will use to confirm initial positive test results.... As the Agency argues, management would be required <span id="page_800"></span>to use the technique specified in Proposal 4 for the duration of the parties' agreement, notwithstanding any revision of section 2.4(f)(1) of the Guidelines. We find that as the proposal would require the use of a particular technique for the duration of the parties' agreement, the proposal establishes a substantive criterion on the exercise of the Agency's right to determine its internal security practices.</p>
<p class="noindent-1">However, we further find that the proposal constitutes a negotiable appropriate arrangement for employees adversely affected by the exercise of that management right.</p>
<p class="noindent-1">The Union states that the intent of the proposal is to ensure that a reliable test is used to guard against inaccurate test results.&#x2003;To this end, the Union states that the proposal requires the Agency to use the best technology available. We find that the proposal thus constitutes an arrangement for employees adversely affected by management's right to determine its internal security practices.</p>
<p class="noindent-1">We further find that the proposal does not excessively interfere with the exercise of management's right. The proposal concerns confirmatory testing of specimens that initially test positive. Employees who test positive may be subject to various personnel actions, including removal from a sensitive position<span class="Italic">. See</span> section 5 of Executive Order 12564. Additionally, those employees also may be subject to disciplinary action. Clearly, it is in the interest of employees to ensure that the best available technology is used for the confirmatory testing process. The risk of inaccurate results, with its attendant negative consequences, thus would be minimized by the use of the GC/MS technique. Therefore, we view the benefits to employees under the proposal to be significant. In contrast, the effect on the Agency would be minimal. The Agency is already required to use the GC/MS technique under section 2.4(f)(1) of the Guidelines. There has been no assertion that a better technique is presently available that could be used by the Agency or that there is an impending change in the requirements of the Guidelines. If the requirement to use the GC/MS technique set forth in the Guidelines were to be changed, however, the Agency, at most, would be required to use the GC/MS only for the duration of the parties' agreement. Also, nothing in the proposal would prevent the Agency from using additional confirmatory techniques, as appropriate. On balance, we conclude that the proposal does not excessively interfere with the Agency's right to determine its internal security practices.</p>
<p class="noindent">The same result was reached in <span class="Italic">AFGE Local 446 and Dept. of Interior, Nat'l Park Serv., Blue Ridge Parkway</span>, 43 FLRA 836, 875, 882 (1991) (Proposal 5C).</p>
<p class="noindent">Distinguishing the split sample cases, discussed below, <span class="Italic">NFFE Local 1384 and Dept. of Air Force, 3245th Air Base Group, Hanscom AFB</span>, 41 FLRA 195, 195-96 (1991), determined that the union could negotiate for a procedure for the agency to separate out a "reserve sample," a quantity of the original sample beyond a certain volume, and to require the agency's contract lab to test that reserve if the original sample tested positive for drugs. The proposal did not violate government-wide testing guidelines and it did not interfere with the right to contract out or to assign work. Similar to <span class="Italic">NFFE Local 1384</span> was FLRA's treatment of a split sample proposal in <span class="Italic">NFFE Local 1953 and Dept. of Air Force, Barksdale AFB</span>, 41 FLRA 332, 332-33 (1991). There was no impediment to the negotiability of a procedure that permitted an employee "to retain any portion of the urine specimen which exceeds the 60 milliliters required for the official sample," and that called on "collection site personnel [to] provide to the employee, upon request, a specimen container together with written instructions for proper storage." <span class="Italic">NTEU and Dept. of Energy</span>, 41 FLRA 1241, 1265, 1266 (1991) (Provision 17).</p>
</section>
</body>
</htmltext>
</html>